Robert Schrepfer

2017

In 2017, Robert Schrepfer earned a total compensation of $1.2M as Senior Vice President, New Business Development and Specialty Sales at ANI Pharmaceuticals, a 45% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$180,000
Option Awards$341,320
Salary$385,504
Stock Awards$328,004
Other$10,497
Total$1,245,325

Schrepfer received $385.5K in salary, accounting for 31% of the total pay in 2017.

Schrepfer also received $180K in non-equity incentive plan, $341.3K in option awards, $328K in stock awards and $10.5K in other compensation.

Rankings

In 2017, Robert Schrepfer's compensation ranked 7,928th out of 14,666 executives tracked by ExecPay. In other words, Schrepfer earned more than 45.9% of executives.

ClassificationRankingPercentile
All
7,928
out of 14,666
46th
Division
Manufacturing
2,976
out of 5,772
48th
Major group
Chemicals And Allied Products
975
out of 2,075
53rd
Industry group
Drugs
761
out of 1,731
56th
Industry
Pharmaceutical Preparations
598
out of 1,333
55th
Source: SEC filing on April 6, 2018.

Schrepfer's colleagues

We found three more compensation records of executives who worked with Robert Schrepfer at ANI Pharmaceuticals in 2017.

2017

Arthur Przybyl

ANI Pharmaceuticals

Chief Executive Officer

2017

Stephen Carey

ANI Pharmaceuticals

Chief Financial Officer

2017

James Marken

ANI Pharmaceuticals

Senior Vice President, Operations and Product Development

News

You may also like